Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase

Journal of Cell Science

Volumn 126, Issue 4, 2013, Pages 989-998

  Bourgeois Daigneault, Marie Claude ^a   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

E3 ubiquitin ligase; Major histocompatibility complex (MHC); MARCH1

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ASSOCIATED RING CH 1 PROTEIN; PARKIN; SIGNAL PEPTIDE; TYROSINE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME CONFORMATION; EXOSOME; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

CELL LINE; FLOW CYTOMETRY; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROSCOPY, FLUORESCENCE; PROTEIN STRUCTURE, TERTIARY; UBIQUITIN-PROTEIN LIGASES;

EID: 84876354754     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.117804     Document Type: Article

References (62)

1. Adhikari, A. and Chen, Z. J. (2009). Diversity of polyubiquitin chains. Dev. Cell 16, 485-486.
2. Bartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K. and Früh, K. (2004). Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78, 1109-1120.
3. Bartee, E., Eyster, C. A., Viswanathan, K., Mansouri, M., Donaldson, J. G. and Früh, K. (2010). Membrane-Associated RING-CH proteins associate with Bap31 and target CD81 and CD44 to lysosomes. PLoS ONE 5, e15132.
4. Berger, A. C. and Roche, P. A. (2009). MHC class II transport at a glance. J. Cell Sci. 122, 1-4.
5. Boname, J. M., de Lima, B. D., Lehner, P. J. and Stevenson, P. G. (2004). Viral degradation of the MHC class I peptide loading complex. Immunity 20, 305-317.
6. Bourgeois-Daigneault, M.-C. and Thibodeau, J. (2012). Autoregulation of MARCH1 expression by dimerization and autoubiquitination. J. Immunol. 188, 4959-4970.
7. Brachet, V., Péhau-Arnaudet, G., Desaymard, C., Raposo, G. and Amigorena, S. (1999). Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments. Mol. Biol. Cell 10, 2891-2904.
8. Brunet, A., Samaan, A., Deshaies, F., Kindt, T. J. and Thibodeau, J. (2000). Functional characterization of a lysosomal sorting motif in the cytoplasmic tail of HLA-DObeta. J. Biol. Chem. 275, 37062-37071.
9. Bujnicki, J. M., Elofsson, A., Fischer, D. and Rychlewski, L. (2001). Structure prediction meta server. Bioinformatics 17, 750-751.
10. Buschow, S. I., Liefhebber, J. M. P., Wubbolts, R. and Stoorvogel, W. (2005). Exosomes contain ubiquitinated proteins. Blood Cells Mol. Dis. 35, 398-403.
11. Cadwell, K. and Coscoy, L. (2008). The specificities of Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases are determined by the positions of lysine or cysteine residues within the intracytoplasmic domains of their targets. J. Virol. 82, 4184-4189.
12. Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S. and Walden, H. (2011). Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30, 2853-2867.
13. Corcoran, K., Jabbour, M., Bhagwandin, C., Deymier, M. J., Theisen, D. L. and Lybarger, L. (2011). Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J. Biol. Chem. 286, 37168-37180.
14. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505- 507.
15. De Gassart, A., Camosseto, V., Thibodeau, J., Ceppi, M., Catalan, N., Pierre, P. and Gatti, E. (2008). MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 105, 3491-3496.
16. Denzin, L. K. and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II a b dimers and facilitates peptide loading. Cell 82, 155-165.
17. Deshaies, R. J. and Joazeiro, C. A. P. (2009). RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434.
18. Dugast, M., Toussaint, H., Dousset, C. and Benaroch, P. (2005). AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J. Biol. Chem. 280, 19656-19664.
19. Escrevente, C., Keller, S., Altevogt, P. and Costa, J. (2011). Interaction and uptake of exosomes by ovarian cancer cells. BMC Cancer 11, 108.
20. Eyster, C. A., Cole, N. B., Petersen, S., Viswanathan, K., Früh, K. and Donaldson, J. G. (2011). MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation. Mol. Biol. Cell 22, 3218-3230.
21. Fallon, L., Bélanger, C. M. L., Corera, A. T., Kontogiannea, M., Regan-Klapisz, E., Moreau, F., Voortman, J., Haber, M., Rouleau, G., Thorarinsdottir, T. et al. (2006). A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat. Cell Biol. 8, 834-842.
22. Galbas, T., Steimle, V., Lapointe, R., Ishido, S. and Thibodeau, J. (2012). MARCH1 down-regulation in IL-10-activated B cells increases MHC class II expression. Cytokine 59, 27-30.
23. Gauvreau, M.-E., Côté, M.-H., Bourgeois-Daigneault, M.-C., Rivard, L. D., Xiu, F., Brunet, A., Shaw, A., Steimle, V. and Thibodeau, J. (2009). Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic 10, 1518-1527.
24. Géminard, C., De Gassart, A., Blanc, L. and Vidal, M. (2004). Degradation of AP2 during reticulocyte maturation enhances binding of hsc70 and Alix to a common site on TFR for sorting into exosomes. Traffic 5, 181-193.
25. Goto, E., Mito-Yoshida, M., Uematsu, M., Aoki, M., Matsuki, Y., Ohmura-Hoshino, M., Hotta, H., Miyagishi, M. and Ishido, S. (2008). An excellent monitoring system for surface ubiquitination-induced internalization in mammals. PLoS ONE 3, e1490.
26. Henn, I. H., Gostner, J. M., Lackner, P., Tatzelt, J. and Winklhofer, K. F. (2005). Pathogenic mutations inactivate parkin by distinct mechanisms. J. Neurochem. 92, 114-122.
27. Hoenicka, J., Vidal, L., Morales, B., Ampuero, I., Jiménez-Jiménez, F. J., Berciano, J., del Ser, T., Jiménez, A., Ruíz, P. G. and de Yébenes, J. G. (2002). Molecular findings in familial Parkinson disease in Spain. Arch. Neurol. 59, 966-970.
28. Hsing, L. C. and Rudensky, A. Y. (2005). The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207, 229-241.
29. Ishido, S., Goto, E., Matsuki, Y. and Ohmura-Hoshino, M. (2009). E3 ubiquitin ligases for MHC molecules. Curr. Opin. Immunol. 21, 78-83.
30. Jabbour, M., Campbell, E. M., Fares, H. and Lybarger, L. (2009). Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression. J. Immunol. 183, 6500-6512.
31. Jahnke, M., Trowsdale, J., and Kelly, A. P. (2012). Ubiquitination of human leukocyte antigen (HLA)-DM by different membrane-associated RING-CH (MARCH) protein family e3 ligases targets different endocytic pathways. J. Biol. Chem. 287, 7256-7264.
32. Kahle, P. J. and Haass, C. (2004). How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep. 5, 681-685.
33. Khalil, H., Brunet, A. and Thibodeau, J. (2005). A three-amino-acid-long HLADRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35. J. Cell Sci. 118, 4679-4687.
34. Kreft, S. G., Wang, L. and Hochstrasser, M. (2006). Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI). J. Biol. Chem. 281, 4646-4653.
35. Landsverk, O. J. B., Bakke, O. and Gregers, T. F. (2009). MHC II and the endocytic pathway: regulation by invariant chain. Scand. J. Immunol. 70, 184-193.
36. Lehner, P. J., Hoer, S., Dodd, R. and Duncan, L. M. (2005). Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207, 112-125.
37. Manoury, B., Mazzeo, D., Li, D. N., Billson, J., Loak, K., Benaroch, P. and Watts, C. (2003). Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 18, 489-498.
38. Mathivanan, S., Ji, H. and Simpson, R. J. (2010). Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920.
39. Matsuki, Y., Ohmura-Hoshino, M., Goto, E., Aoki, M., Mito-Yoshida, M., Uematsu, M., Hasegawa, T., Koseki, H., Ohara, O., Nakayama, M. et al. (2007). Novel regulation of MHC class II function in B cells. EMBO J. 26, 846-854.
40. McCormick, P. J., Martina, J. A. and Bonifacino, J. S. (2005). Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl. Acad. Sci. USA 102, 7910-7915.
41. Miyazono, K. and Koinuma, D. (2011). Arkadia-beyond the TGF-b pathway. J. Biochem. 149, 1-3.
42. Nathan, J. A. and Lehner, P. J. (2009). The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp. Cell Res. 315, 1593-1600.
43. Nilsson, T., Jackson, M. and Peterson, P. A. (1989). Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum. Cell 58, 707-718.
44. Ohmura-Hoshino, M., Goto, E., Matsuki, Y., Aoki, M., Mito, M., Uematsu, M., Hotta, H. and Ishido, S. (2006). A novel family of membrane-bound E3 ubiquitin ligases. J. Biochem. 140, 147-154.
45. Quah, B. J. C. and O'Neill, H. C. (2005). The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol. Dis. 35, 94-110.
46. Rankin, C. A., Roy, A., Zhang, Y. and Richter, M. (2011). Parkin, a top level manager in the cell's Sanitation Department. Open Biochem. J. 5, 9-26.
47. Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J., Yokoyama, S., Yamada, S., Kawahara, H., Yokosawa, H., Hattori, N., Mizuno, Y. et al. (2003). Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301-306.
48. Salamero, J., Le Borgne, R., Saudrais, C., Goud, B. and Hoflack, B. (1996). Expression of major histocompatibility complex class II molecules in HeLa cells promotes the recruitment of AP-1 Golgi-specific assembly proteins on Golgi membranes. J. Biol. Chem. 271, 30318-30321.
49. Shin, J.-S., Ebersold, M., Pypaert, M., Delamarre, L., Hartley, A. and Mellman, I. (2006). Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118.
50. Simons, M. and Raposo, G. (2009). Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581.
51. Szöllosi, J., Damjanovich, S. and Mátyus, L. (1998). Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. Cytometry 34, 159-179.
52. ten Broeke, T., van Niel, G., Wauben, M. H. M., Wubbolts, R. and Stoorvogel, W. (2011). Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 12, 1025-1036.
53. Théry, C., Zitvogel, L. and Amigorena, S. (2002). Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579.
54. Thibodeau, J., Bourgeois-Daigneault, M.-C., Huppé, G., Tremblay, J., Aumont, A., Houde, M., Bartee, E., Brunet, A., Gauvreau, M. E., de Gassart, A. et al. (2008). Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38, 1225-1230.
55. Tomoo, K., Mukai, Y., In, Y., Miyagawa, H., Kitamura, K., Yamano, A., Shindo, H. and Ishida, T. (2008). Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin. Biochim. Biophys. Acta 1784, 1059-1067.
56. Tze, L. E., Horikawa, K., Domaschenz, H., Howard, D. R., Roots, C. M., Rigby, R. J., Way, D. A., Ohmura-Hoshino, M., Ishido, S., Andoniou, C. E. et al. (2011). CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208, 149-165.
57. van Bergen En Henegouwen, P. (2009). Eps15: a multifunctional adaptor protein regulating intracellular trafficking. Cell Commun. Signal. 7, 24.
58. van Niel, G., Wubbolts, R., Ten Broeke, T., Buschow, S. I., Ossendorp, F. A., Melief, C. J., Raposo, G., van Balkom, B. W. and Stoorvogel, W. (2006). Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25, 885-894.
59. Walseng, E., Bakke, O. and Roche, P. A. (2008). Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway. J. Biol. Chem. 283, 14717-14727.
60. Walseng, E., Furuta, K., Bosch, B., Weih, K. A., Matsuki, Y., Bakke, O., Ishido, S. and Roche, P. A. (2010). Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. USA 107, 20465- 20470.
61. Wang, X., Herr, R. A. and Hansen, T. (2008). Viral and cellular MARCH ubiquitin ligases and cancer. Semin. Cancer Biol. 18, 441-450.
62. Ye, Y. and Rape, M. (2009). Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10, 755-764